Neuronal nitric oxide synthase is refractory to mechanism-based inactivation in GH3 pituitary cells

被引:9
作者
Cooper, GR [1 ]
Barr, A [1 ]
Wolff, DJ [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA
关键词
GH(3) pituitary cells; Ca2+; NO formation; inactivation; inhibition; nNOS; mechanism-based inactivation;
D O I
10.1006/abbi.1998.0828
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide formation by GH(3) pituitary cells is stimulated by depolarizing concentrations of K+ and by the L-channel Ca2+ agonist Bay k 8644 in an additive manner that depends on extracellular Ca2+. Ca2+-dependent NO formation at 100 mu M arginine was inhibited 50% over a 30-min period by 5 mu M N-G-amino-L-arginine, 30 mu M N-6-iminoethyl-L-ornithine (NIO), and 520 mu M N-5-iminoethyl-L-lysine (ML) but required concentrations of aminoguanidine (AG) greater than 3 mM. As measured at 100 mu M extracellular arginine, intracellular neuronal nitric oxide synthase (nNOS) was inactivated 50% over a 30-min period by 150 mu M N-G-amino-L-arginine and 1500 mu M MO, but required concentrations of ML or AG greater than 5 mM. The inactivation of nNOS by these agents occurred only under conditions that mobilized extracellular Ca2+ and was inhibited by increased extracellular arginine. Thus these agents inhibit cellular Ca2+-dependent NO formation at concentrations far lower than those required to inactivate the cellular nNOS. Inhibition of NO formation by these agents was not attributable to effects on cellular arginine uptake. In contrast diphenyliodonium chloride produced a rapid and complete inactivation of cellular NO formation and nNOS activity. These inactivations produced by diphenyliodonium chloride occurred with identical kinetics but displayed no requirement for Ca2+. These data support the assertion that neuronal NO synthase is refractory to mechanism-based inactivation in GH(3) pituitary cells. (C) 1998 Academic Press.
引用
收藏
页码:195 / 206
页数:12
相关论文
共 27 条
[21]   CHARACTERIZATION OF 3 INHIBITORS OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE INVITRO AND INVIVO [J].
REES, DD ;
PALMER, RMJ ;
SCHULZ, R ;
HODSON, HF ;
MONCADA, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (03) :746-752
[22]   INHIBITION OF MACROPHAGE AND ENDOTHELIAL-CELL NITRIC-OXIDE SYNTHASE BY DIPHENYLENEIODONIUM AND ITS ANALOGS [J].
STUEHR, DJ ;
FASEHUN, OA ;
KWON, NS ;
GROSS, SS ;
GONZALEZ, JA ;
LEVI, R ;
NATHAN, CF .
FASEB JOURNAL, 1991, 5 (01) :98-103
[23]   INHIBITION OF CYTOCHROME-P(450) REDUCTASE BY THE DIPHENYLIODONIUM CATION - KINETIC-ANALYSIS AND COVALENT MODIFICATIONS [J].
TEW, DG .
BIOCHEMISTRY, 1993, 32 (38) :10209-10215
[24]   Inactivation of nitric oxide synthase isoforms by diaminoguanidine and N-G-amino-L-arginine [J].
Wolff, DJ ;
Lubeskie, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 325 (02) :227-234
[25]   AMINOGUANIDINE IS AN ISOFORM-SELECTIVE, MECHANISM-BASED INACTIVATOR OF NITRIC-OXIDE SYNTHASE [J].
WOLFF, DJ ;
LUBESKIE, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 316 (01) :290-301
[26]   IDENTIFICATION AND CHARACTERIZATION OF A CALMODULIN-DEPENDENT NITRIC-OXIDE SYNTHASE FROM GH3 PITUITARY-CELLS [J].
WOLFF, DJ ;
DATTO, GA .
BIOCHEMICAL JOURNAL, 1992, 285 :201-206
[27]   Inactivation and recovery of nitric oxide synthetic capability in cytokine-induced RAW 264.7 cells treated with ''irreversible'' NO synthase inhibitors [J].
Wolff, DJ ;
Lubeskie, A ;
Li, C .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 338 (01) :73-82